USA - NASDAQ:MASI - US5747951003 - Common Stock
The current stock price of MASI is 151.2 USD. In the past month the price increased by 5.42%. In the past year, price increased by 9.32%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.33 | 233.10B | ||
ISRG | INTUITIVE SURGICAL INC | 55.48 | 160.10B | ||
BSX | BOSTON SCIENTIFIC CORP | 34.34 | 144.02B | ||
SYK | STRYKER CORP | 28.98 | 142.35B | ||
MDT | MEDTRONIC PLC | 17.54 | 124.42B | ||
BDX | BECTON DICKINSON AND CO | 13.6 | 55.64B | ||
IDXX | IDEXX LABORATORIES INC | 52.01 | 49.97B | ||
EW | EDWARDS LIFESCIENCES CORP | 29.27 | 44.16B | ||
RMD | RESMED INC | 29.7 | 41.53B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.94 | 33.91B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 16.87 | 27.13B | ||
DXCM | DEXCOM INC | 39.88 | 26.58B |
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. The company is headquartered in Irvine, California and currently employs 3,600 full-time employees. The company went IPO on 2007-08-08. The firm's segments include healthcare and non-healthcare. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The firm primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities and consumers. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company’s non-healthcare consumer business incorporates audio and home integration technologies that are primarily sold or licensed directly to consumers, or through authorized retailers and wholesalers.
MASIMO CORP
52 Discovery
Irvine CALIFORNIA 92618 US
CEO: Joe Kiani
Employees: 3600
Phone: 19492977000
The current stock price of MASI is 151.2 USD. The price decreased by -1.64% in the last trading session.
The exchange symbol of MASIMO CORP is MASI and it is listed on the Nasdaq exchange.
MASI stock is listed on the Nasdaq exchange.
15 analysts have analysed MASI and the average price target is 190.86 USD. This implies a price increase of 26.23% is expected in the next year compared to the current price of 151.2. Check the MASIMO CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MASIMO CORP (MASI) has a market capitalization of 8.21B USD. This makes MASI a Mid Cap stock.
MASIMO CORP (MASI) currently has 3600 employees.
MASIMO CORP (MASI) has a support level at 149.82 and a resistance level at 155.72. Check the full technical report for a detailed analysis of MASI support and resistance levels.
The Revenue of MASIMO CORP (MASI) is expected to decline by -27.11% in the next year. Check the estimates tab for more information on the MASI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MASI does not pay a dividend.
MASIMO CORP (MASI) will report earnings on 2025-11-03, after the market close.
The PE ratio for MASIMO CORP (MASI) is 28.31. This is based on the reported non-GAAP earnings per share of 5.34 and the current share price of 151.2 USD. Check the full fundamental report for a full analysis of the valuation metrics for MASI.
The outstanding short interest for MASIMO CORP (MASI) is 7.28% of its float. Check the ownership tab for more information on the MASI short interest.
ChartMill assigns a technical rating of 4 / 10 to MASI. When comparing the yearly performance of all stocks, MASI turns out to be only a medium performer in the overall market: it outperformed 46.3% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to MASI. Both the profitability and the financial health of MASI get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months MASI reported a non-GAAP Earnings per Share(EPS) of 5.34. The EPS increased by 60.84% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -19.11% | ||
ROE | -44.04% | ||
Debt/Equity | 0.57 |
15 analysts have analysed MASI and the average price target is 190.86 USD. This implies a price increase of 26.23% is expected in the next year compared to the current price of 151.2.
For the next year, analysts expect an EPS growth of 27% and a revenue growth -27.11% for MASI